ID   NCC-MLPS1-C1
AC   CVCL_A1VS
DR   Wikidata; Q105510296
RX   PubMed=33146842;
WW   https://en.cellline.jp/product/ncc-mlps1-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 98 hours (PubMed=33146842).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=33146842).
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=33146842
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,14
ST   D16S539: 9,10
ST   D21S11: 30,32.2
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
RX   PubMed=33146842; DOI=10.1007/s13577-020-00454-3;
RA   Noguchi R., Yoshimatsu Y., Sei A., Hirabayashi K., Ozawa I.,
RA   Kikuta K., Kondo T.;
RT   "Establishment and characterization of NCC-MLPS1-C1: a novel
RT   patient-derived cell line of myxoid liposarcoma.";
RL   Hum. Cell 34:667-674(2021).
//